MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

But these two billionaires aren't attracted to the same stocks very often. Buffett's Berkshire Hathaway portfolio includes 41 ...

In a report released yesterday, Bob Huang from Morgan Stanley maintained a Buy rating on Metlife (MET – Research Report), with a price ...

On Monday, Metlife Inc (MET) stock saw a decline, ending the day at $84.84 which represents a decrease of $-0.48 or -0.56% from the prior close of $85.32. The stock opened at $85.33 and touched a low ...

Livelsberger Financial Advisory acquired a new stake in Walmart Inc. (NYSE:WMT – Free Report) during the 3rd quarter, ...

New York-based MetLife, Inc. (MET) is a global financial services company, specializing in insurance, annuities, employee ...

(Reuters) - New York-based insurer MetLife Inc is in advanced talks to buy PineBridge Investments' assets outside of China in ...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 16.49% ...

Compared to the aggregate P/E ratio of 18.7 in the Insurance industry, MetLife Inc. has a higher P/E ratio of 23.15.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.

Vertex’s core cystic fibrosis portfolio remains its top/bottom-line driver, with elongated patent expiry for TRIKAFTA/KAFTRIO ...